Revance Therapeutics Inc 's

• RVNC's Stock Performance relative to its Competitors

Landos Biopharma Inc Share Performance +309.46% This Quarter

Landos Biopharma Inc Profile Lando's Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing innovative biopharmaceutical products to address unmet medical needs. Their business model revolves around conducting research and development, obtaining regulatory approvals, and marketing and selling their products in the global pharmaceutical market. More about Landos Biopharma Inc 's Market Share

Ocular Therapeutix Inc Share Performance -17.40% One Year

Ocular Therapeutix Inc Profile Ocular Therapeutix Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for diseases and conditions of the eye. They utilize their proprietary hydrogel technology to design and manufacture sustained-release treatments that can be administered during routine eye exams and eliminate the need for patient compliance with eye drops. More about Ocular Therapeutix Inc 's Market Share

Organon and Co Share Performance +90.06% This Year

Organon and Co Profile Organon and Co's business model revolves around developing and manufacturing pharmaceutical products. More about Organon and Co 's Market Share

Pfizer Inc Share Performance +13.03% This Year

Pfizer Inc Profile Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth. More about Pfizer Inc's Market Share

Phathom Pharmaceuticals Inc Share Performance -39.08% This Year

Phathom Pharmaceuticals Inc Profile Phathom Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing treatments for gastrointestinal diseases. Their business model involves advancing their pipeline of drug candidates through research and development, and seeking regulatory approval for commercialization. By strategically targeting unmet medical needs in the gastrointestinal space, Phathom Pharmaceuticals aims to provide innovative solutions to improve patient outcomes. More about Phathom Pharmaceuticals Inc 's Market Share

Sources: Revance Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 4:49 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Revance Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.